Directors & Advisors

Scott FloraBOARD OF DIRECTORS

Scott Flora has over 30 years of Medical Device Experience in Implantable Devices and Surgical Instruments and Systems. He has held Global Leadership positions with Smith & Nephew and Covidien in Ophthalmic, Orthopedics and General Surgery. Mr. Flora started his career at J&J McNeil in sales before moving on to sales roles at Pilling Instruments and Cilco Intra Ocular Lenses.

In 1988 Mr. Flora joined the successful startup IOPTEX as a sales rep eventually moving up to Global Vice President of Sales and Marketing after the acquisition by Smith & Nephew. In 1994 Ioptex was divested to Allergan and Mr. Flora joined the Orthopedic Team at Smith & Nephew in Memphis TN, where he held leadership roles in Sales US Orthopedics and Endoscopy as well as Orthopedics for Europe. In 2002 he was appointed Division President for Trauma and Recon in 2005. In 2006 Mr. Flora joined Covidien pre spin from Tyco as President of the Surgical Device GBU. In 2011 Mr. Flora joined Omni Guide as its CEO and member of the Board until 2014.

Mr. Flora has also had Board roles as an independent director with the following companies. Tengion 2011- 2012, MAKO Surgical 2013, AgNovos Health Care 2013 to present, NovaTract 2015 to present, COTERA 2015 to present. As well as Board Roles Mr. Flora serves as an Advisor to Invuity and sits on the Medical Advisory Council for Flextronics. In 2015 Mr. Flora established Scott Flora Consulting a private management consulting firm.

Mr. Flora has BS in Marketing from Millikin University in Decatur Ill. where he was an All-Conference Football Player. Mr. Flora remains an active Alumnus and served on the Board of Trustee’s for two years. Mr. Flora has also participated in Executive Development Programs at Wharton, INSEAD, Kellogg and Yale.
During his career he participated in community giving through United Way, Junior Achievement and support for local Educational Programs where he was recognized for his giving and support.

Dr. Alan KerseyBOARD OF DIRECTORS

Dr. Alan Kersey has been engaged in sensor technology research and commercialization for the past 3 decades. His research work began in 1981 at the University of Kent, which was followed by a 14 year tenure at the Naval Research Laboratory (NRL) in Washington DC. At NRL his focus on advanced fiber optic based sensing concepts, led to some of the seminal research on Bragg grating sensor systems.

In 1997, Alan joined a start-up, CiDRA, as it’s founding Chief Technology Officer, to develop fiber Bragg grating sensors for the Oil & Gas industry. He served on CiDRA’s board from 2001 to 2003. From 2003 to 2005, he was CEO of CyVera, a spin-out from CiDRA which developed a genetic analysis/assay platform – BeadXpress. Just prior to the commercial launch of the platform, CyVera was acquired by the leading genetic sequencing company, Illumina. Following this acquisition, Alan was VP & General Manager of Illumina’s division based in Cambridge, UK. Most recently, he re-joined CiDRA in an M&A role, to bring new sensor technologies to the suite the company has already developed & successfully deployed in industrial applications.

Currently Alan serves as a Non-Executive Director on the Board of Industrial Tomography Systems (ITS) in the UK, and as a member of the Technical Advisory Boards of Insight Photonics, and Taff Optical. He is also currently engaged in the formation of several new biotech start-ups in Connecticut under a new entity CyOmics LLC.

Alan holds a B.Sc in Physics & Electronics at the University of Warwick, a Ph.D from the University of Leeds, and is a Fellow of the Optical Society of America. He has published extensively in journal and conference forums, and holds over 100 patents in optical sensing and instrumentation.

Louise M. DembryMD, MS, MBA – ADVISOR

Dr. Dembry joined the faculty of the Yale University School of Medicine in 1993 after completing her Infectious Diseases fellowship at Wayne State University in Detroit, Michigan. She is currently Professor of Medicine and Associate Professor of Epidemiology. Upon joining Yale, she initially served as the Yale-New Haven Hospital Associate Hospital Epidemiologist, Epidemiology Laboratory Director and VA Connecticut Healthcare System Hospital Epidemiologist. In 2001 she was appointed Hospital Epidemiologist for Yale-New Haven Hospital; a position in which she served until October 2012. She is currently Associate Director of Hospital Epidemiology for the newly integrated Yale-New Haven Hospital and former Hospital of St. Raphael Hospital Epidemiology programs.

Her main interests include 1) the prevention and control of transmission of antibiotic resistant organisms in healthcare settings, 2) healthcare facility public health emergency preparedness and 3) training and education for hospital epidemiology and public health emergencies. She has mentored eleven Yale ID Fellows during one-year Hospital Epidemiology Fellowships performed under her supervision, she directs the Yale School of Public Health Healthcare Epidemiology course that is taught annually, has published more than 60 peer reviewed articles and book chapters, and serves on several state and national committees and councils (AHRQ National Advisory Council 2010-1012).

In 2008, Dr. Dembry completed her MBA degree program. She decided to go to business school in 2006 in order to gain formal education and training in skills that hospital epidemiologists are called upon to use daily in their work: program development and management, strategy and strategic thinking as well as leadership and staff development to name a few. She is excited about using her experience and knowledge to help others be as effective as they can be in all aspects of their roles as hospital epidemiologists.

Patrick O’NeilBOARD OF DIRECTORS

Patrick leads CI investments in the clean technology, industrial/energy technologies, life sciences, software and digital media sectors.

Previously, Patrick was a project manager for the Connecticut Clean Energy Fund’s On-Site Renewable Distributed Generation Program and Project 100. He provided financial analysis on renewable energy projects that utilized diverse technologies, including fuel cells, solar photovoltaics, and hydro and sustainable biomass. Patrick’s experience also includes tenures at UTC Power, Duke Engineering and Services (now Areva NP Inc.) and Yankee Atomic Electric Corporation.

Patrick holds a B.S. in Nuclear Engineering, University of Massachusetts at Lowell, an M.S., Mechanical Engineering from Worcester Polytechnic Institute and an M.B.A. in Finance from New York University Stern School of Business. He is also a licensed engineer in the state of Connecticut.